- Global Surge in Mycoplasma Pneumoniae Infections Sparks Expert Warnings
- Discovery of New Targets for Treating Cancer and Age-Related Diseases
- Why Blood Sugar Levels Increase in Winter?
- Zepbound: Eli Lilly new weight-loss drug 20% cheaper than Wegovy
- US$300K: Compensation Granted as Woman Dies Following COVID-19 Vaccination
- Gut Bacteria Enhance Cancer Immunotherapy: Study Reveals Potential Role of Lactobacillus reuteri
Indonesia: SINOVAC COVID-19 vaccines’ trial results are “quite good”
Indonesia: SINOVAC COVID-19 vaccines’ trial results are “quite good”. China’s vaccines were dispensed nationwide today. The spokesperson of the Indonesian Ministry of Health: China SINOVAC’s vaccine clinical trial results are “quite good”.
[Global Network Report, Reporter Zhang Xiaoya] According to Singapore’s “Straits Times” report on the 3rd, Indonesia today began to distribute the COVID-19 vaccine developed by China SINOVAC Company across the country.
According to the report, Indonesian vaccine manufacturer Bio Farma spokesperson Bambang Heriyanto (Bambang Heriyanto) said that the agency began today to distribute biotechnology from China’s SINOVAC to health institutions in 34 provinces and regions across Indonesia. The COVID-19 vaccine developed by the company.
The spokesperson also said at the press conference that the storage facilities required for vaccines are ready, “All (vaccine) cold chain facilities with temperatures between 2 degrees Celsius and 8 degrees Celsius are ready. Hope this will help Ensuring the quality of vaccines for the people”.
According to the report, at the same press conference, Siti Nadia Tarmizi, the spokesperson of the Indonesian Ministry of Health in charge of vaccines, said that the vaccine of China SINOVAC has achieved clinical trials in Turkey and Brazil. The “fairly good” effect is the same as the results of the third phase of the ongoing Indonesian clinical trial.
“We are very optimistic that (the plan) will proceed according to our schedule, and we can start the vaccination in the second or third week of January 2021.” Tamiz said.
In August 2020, Indonesia and SINOVAC launched a cooperation on the third phase of vaccine clinical trials. According to the Chinese Embassy in Indonesia, on August 26, Indonesian vaccine manufacturer Bio Farma and SINOVAC signed the first batch of COVID-19 vaccine delivery agreements. According to a British Reuters report, on December 6, the Indonesian government announced that it had received 1.2 million doses of the COVID-19 vaccine from China SINOVAC; on December 31, Indonesia received the second batch of 1.8 million doses of vaccine from China SINOVAC.
(source:internet, reference only)